UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy

International journal of molecular sciences, 2019-06, Vol.20 (11), p.2839

2019

Volltextzugriff (PDF)

BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 Antibody

Clinical cancer research, 2018-07, Vol.24 (14), p.3377-3385

2018

Volltextzugriff (PDF)

Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy

Journal of experimental & clinical cancer research, 2022-10, Vol.41 (1), p.1-309, Article 309

2022

Volltextzugriff (PDF)

Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective

Cells (Basel, Switzerland), 2021-03, Vol.10 (3), p.543

2021

Volltextzugriff (PDF)

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST

International journal of molecular sciences, 2022-09, Vol.23 (18), p.10368

2022

Volltextzugriff (PDF)

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma

Journal of experimental & clinical cancer research, 2023-11, Vol.42 (1), p.1-310, Article 310

2023

Volltextzugriff (PDF)

Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models

Cancers, 2021-05, Vol.13 (10), p.2302

2021

Volltextzugriff (PDF)

Next generation immune-checkpoints for cancer therapy

Journal of thoracic disease, 2018-05, Vol.10 (Suppl 13), p.S1581-S1601

2018

Volltextzugriff (PDF)

Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification

Molecular therapy, 2024-08, Vol.32 (8), p.2741-2761

2024

Volltextzugriff (PDF)

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes

Clinical cancer research, 2020-12, Vol.26 (23), p.6321-6334

2020

Volltextzugriff (PDF)

Full chimaeric CAR . CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers

British journal of haematology, 2023-01, Vol.200 (1), p.64-69

2023

Volltextzugriff (PDF)

Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers

British journal of haematology, 2023-01, Vol.200 (1), p.64-69

2023

Volltextzugriff (PDF)

Abstract 885: Anti-CSPG4 CAR.CIK lymphocytes are effective against advanced sarcomas in 3D spheroid and xenograft models

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.885-885

2020

Volltextzugriff (PDF)

Abstract 3234: PD-1 is intrinsically expressed by lung cancer cells with stemness features inhibited by PD-1 blockade

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3234-3234

2019

Volltextzugriff (PDF)

Abstract 3591: CSPG4 as innovative target for CAR redirected CIK lymphocytes against soft tissue sarcomas

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3591-3591

2018

Volltextzugriff (PDF)

Abstract 3998: Preclinical efficacy of a synthetic Notch-based combinatorial immunotherapy against colorectal cancer with HER2 amplification

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.3998-3998

2024

Volltextzugriff (PDF)

190 Novel cellular immunotherapy with anti-mesothelin CAR-killer lymphocytes against advanced cholangiocarcinoma

Journal for immunotherapy of cancer, 2022-11, Vol.10 (Suppl 2), p.A202-A202

2022

Volltextzugriff (PDF)

Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.5603-5603

2017

Volltextzugriff (PDF)

Abstract 3194: Anti-mesothelin CAR.CIK lymphocytes are effective against ovarian cancer in 3D models of peritoneal carcinomatosis

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.3194-3194

2023

Volltextzugriff (PDF)

Abstract 2812: CSPG4-specific CAR.CIK lymphocyte-based immunotherapy to eliminate HLA class I-defective melanoma tumors

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2812-2812

2022

Volltextzugriff (PDF)

Towards collective protections for crowdworkers: Italy, Spain and France in the EU context

Transfer (Brussels, Belgium), 2017-05, Vol.23 (2), p.207-223

2017

Volltextzugriff (PDF)

Negative association between trunk fat, insulin resistance and skeleton in obese women

World journal of diabetes, 2013-04, Vol.4 (2), p.31-39

2013

Volltextzugriff (PDF)

Current state-of-the-art in the use of plants for the production of recombinant vaccines against infectious bursal disease virus

Applied microbiology and biotechnology, 2020-03, Vol.104 (6), p.2287-2296

2020

Volltextzugriff (PDF)

BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis

Scientific reports, 2017-02, Vol.7 (1), p.42801-42801, Article 42801

2017

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(87)
Mit Volltextzugriff
(92)

Publikationsform

Artikel
(94)
Buchkapitel
(2)

Sprache

Englisch
(95)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(54)
Humans
(29)
Oncology
(13)
Biotechnology & Applied Microbiology
(11)
Lymphocytes
(11)
Biochemistry & Molecular Biology
(10)
Cancer
(10)
Immunotherapy
(10)
Physical Sciences
(9)
Proteins
(9)
Tumors
(9)
Animals
(8)
Biotechnology
(8)
Cytokines
(8)
Medicine
(8)
Molecular Farming
(8)
Obesity
(8)
Patients
(8)
Antibodies
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy

BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 Antibody

Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy

Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective

Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST

CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma

Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models

Next generation immune-checkpoints for cancer therapy

Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells

Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification

CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes

Full chimaeric CAR . CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers

Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers

Abstract 885: Anti-CSPG4 CAR.CIK lymphocytes are effective against advanced sarcomas in 3D spheroid and xenograft models

Abstract 3234: PD-1 is intrinsically expressed by lung cancer cells with stemness features inhibited by PD-1 blockade

Abstract 3591: CSPG4 as innovative target for CAR redirected CIK lymphocytes against soft tissue sarcomas

Abstract 3998: Preclinical efficacy of a synthetic Notch-based combinatorial immunotherapy against colorectal cancer with HER2 amplification

190 Novel cellular immunotherapy with anti-mesothelin CAR-killer lymphocytes against advanced cholangiocarcinoma

Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies

Abstract 3194: Anti-mesothelin CAR.CIK lymphocytes are effective against ovarian cancer in 3D models of peritoneal carcinomatosis

Abstract 2812: CSPG4-specific CAR.CIK lymphocyte-based immunotherapy to eliminate HLA class I-defective melanoma tumors

Towards collective protections for crowdworkers: Italy, Spain and France in the EU context

Negative association between trunk fat, insulin resistance and skeleton in obese women

Current state-of-the-art in the use of plants for the production of recombinant vaccines against infectious bursal disease virus

BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis

Suchergebnisse filtern